Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men

In-vitro studies have suggested that the antiarrhythmic drug digoxin might restrain the growth of cancer cells by inhibiting Na+/K+-ATPase. We evaluated the association between cancer mortality and digoxin, sotalol and general antiarrhythmic drug use in a retrospective cohort study. The study popula...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaapu, Kalle J., Rantaniemi, Lauri, Talala, Kirsi, Taari, Kimmo, Tammela, Teuvo L. J., Auvinen, Anssi, Murtola, Teemu J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037774/
https://www.ncbi.nlm.nih.gov/pubmed/29985440
http://dx.doi.org/10.1038/s41598-018-28541-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037774/
https://www.ncbi.nlm.nih.gov/pubmed/29985440
http://dx.doi.org/10.1038/s41598-018-28541-4

Ejemplares similares